The new indications for biologicals in type 2 diseases: perspectives
Sign Up to like & getrecommendations! Published in 2022 at "Current Opinion in Allergy and Clinical Immunology"
DOI: 10.1097/aci.0000000000000862
Abstract: Purpose of review To provide a literature review of what is on the market and under study for some diseases treated with drugs targeting type 2 (T2) inflammation. Recent findings Literature data have shown that… read more here.
Keywords: type diseases; diseases perspectives; biologicals type; indications biologicals ... See more keywords
New Indications of Biological Drugs in Allergic and Immunological Disorders: Beyond Asthma, Urticaria, and Atopic Dermatitis
Sign Up to like & getrecommendations! Published in 2023 at "Biomedicines"
DOI: 10.3390/biomedicines11020236
Abstract: Asthma, chronic urticaria, and atopic dermatitis are some of the most numerous allergic diseases affecting children. Recent advances in the understanding of their specific intracellular molecular pathways have led to the approval of monoclonal antibodies… read more here.
Keywords: atopic dermatitis; new indications; biological drugs; urticaria atopic ... See more keywords
Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series
Sign Up to like & getrecommendations! Published in 2017 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v23.i39.7174
Abstract: Fecal microbiota transplantation (FMT) is effective in recurrent Clostridium difficile infection (rCDI). Knowledge of the safety and efficacy of FMT treatment in immune deficient patients is scarce. FMT has been suggested as a potential method… read more here.
Keywords: clostridium difficile; microbiota transplantation; rcdi; new indications ... See more keywords